id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0275-0003,FDA,FDA-2010-P-0275,"Determinations that Product Withdrawal From Sale Was Not for Reasons of Safety or Effectiveness: GLEEVEC (Imatinib Mesylate) Capsules, 50 Milligrams and 100 Milligrams",Notice,N-Notice,2010-12-07T05:00:00Z,2010,12,2010-12-07T05:00:00Z,,2010-12-07T15:24:43Z,2010-30570,0,0,0900006480bb0be6
FDA-2010-P-0275-0001,FDA,FDA-2010-P-0275,"Hyman Phelps & McNamara, P.C. - Citizen Petition",Other,CP-Citizen Petition,2010-06-14T04:00:00Z,2010,6,2010-06-14T04:00:00Z,,2024-11-12T04:51:12Z,,1,0,0900006480afb1e0
FDA-2010-P-0275-0002,FDA,FDA-2010-P-0275,"Acknowledgement Letter to Hyman Phelps & McNamara, P.C.",Other,ACK-Acknowledgement Letter,2010-06-14T04:00:00Z,2010,6,2010-06-14T04:00:00Z,,2013-07-27T23:20:57Z,,0,0,0900006480afb2a6